Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 37

1.

Anti-Apoptotic Effects of Recombinant Human Hepatocyte Growth Factor on Hepatocytes Were Associated with Intrahepatic Hemorrhage Suppression Indicated by the Preservation of Prothrombin Time.

Motoi S, Toyoda H, Obara T, Ohta E, Arita Y, Negishi K, Moriya K, Kuboi Y, Soejima M, Imai T, Ido A, Tsubouchi H, Kawano T.

Int J Mol Sci. 2019 Apr 12;20(8). pii: E1821. doi: 10.3390/ijms20081821.

2.

Pharmacokinetics, Pharmacodynamics, and Safety of E6011, a Novel Humanized Antifractalkine (CX3CL1) Monoclonal Antibody: A Randomized, Double-Blind, Placebo-Controlled Single-Ascending-Dose Study.

Tabuchi H, Katsurabara T, Mori M, Aoyama M, Obara T, Yasuda N, Kawano T, Imai T, Ieiri I, Kumagai Y.

J Clin Pharmacol. 2019 May;59(5):688-701. doi: 10.1002/jcph.1361. Epub 2018 Dec 21.

PMID:
30575978
3.

Cystometric evaluation of recovery in hypocompliant defunctionalized bladder as a result of long-term dialysis after kidney transplantation.

Inoue T, Satoh S, Obara T, Saito M, Numakura K, Narita S, Tsuchiya N, Habuchi T.

Int J Urol. 2016 Aug;23(8):694-700. doi: 10.1111/iju.13122. Epub 2016 May 15.

4.

COMPARISON BETWEEN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY AT 120 AND 60 SHOCKWAVES PER MINUTE FOR TREATMENT OF URINARY STONES.

Kashima S, Horikawa Y, Obara T, Muto Y, Koizumi A, Honma N, Akihama S, Shimoda N.

Nihon Hinyokika Gakkai Zasshi. 2016;107(2):93-99. doi: 10.5980/jpnjurol.107.93. Japanese.

5.

Corrigendum: Identification of the phytosphingosine metabolic pathway leading to odd-numbered fatty acids.

Kondo N, Ohno Y, Yamagata M, Obara T, Seki N, Kitamura T, Naganuma T, Kihara A.

Nat Commun. 2015 Apr 2;6:6815. doi: 10.1038/ncomms7815. No abstract available.

PMID:
25832904
6.

Identification of the phytosphingosine metabolic pathway leading to odd-numbered fatty acids.

Kondo N, Ohno Y, Yamagata M, Obara T, Seki N, Kitamura T, Naganuma T, Kihara A.

Nat Commun. 2014 Oct 27;5:5338. doi: 10.1038/ncomms6338. Erratum in: Nat Commun. 2015;6:6815.

PMID:
25345524
7.

Laparoendoscopic single-site plus one trocar donor nephrectomy using the GelPort: initial clinical experience.

Inoue T, Tsuchiya N, Narita S, Saito M, Maita S, Numakura K, Obara T, Tsuruta H, Horikawa Y, Satoh S, Habuchi T.

Urology. 2013 Feb;81(2):308-12. doi: 10.1016/j.urology.2012.09.048.

PMID:
23374790
8.

Comparison of surgical stress in patients undergoing open versus laparoscopic radical prostatectomy by measuring perioperative serum cytokine levels.

Narita S, Tsuchiya N, Kumazawa T, Maita S, Numakura K, Obara T, Tsuruta H, Saito M, Inoue T, Horikawa Y, Satoh S, Habuchi T.

J Laparoendosc Adv Surg Tech A. 2013 Jan;23(1):33-7. doi: 10.1089/lap.2012.0348. Epub 2012 Dec 21.

PMID:
23259574
9.

Association between various indices of obesity and intraoperative factors in laparoscopic donor nephrectomy.

Kumazawa T, Tsuchiya N, Inoue T, Obara T, Tsuruta H, Saito M, Narita S, Horikawa Y, Satoh S, Habuchi T.

J Laparoendosc Adv Surg Tech A. 2012 Jul-Aug;22(6):567-71. doi: 10.1089/lap.2011.0472. Epub 2012 Jun 25.

PMID:
22731803
10.

Hyperuricemia at 1 year after renal transplantation, its prevalence, associated factors, and graft survival.

Numakura K, Satoh S, Tsuchiya N, Saito M, Maita S, Obara T, Tsuruta H, Inoue T, Narita S, Horikawa Y, Kagaya H, Miura M, Habuchi T.

Transplantation. 2012 Jul 27;94(2):145-51. doi: 10.1097/TP.0b013e318254391b.

PMID:
22728291
11.

Comparison of the clinical outcome and systemic inflammatory marker levels between retroperitoneal and transperitoneal laparoscopic donor nephrectomy.

Saito M, Tsuchiya N, Narita S, Kumazawa T, Maita S, Numakura K, Obara T, Tsuruta H, Inoue T, Horikawa Y, Satoh S, Habuchi T.

J Endourol. 2012 Aug;26(8):1038-43. doi: 10.1089/end.2012.0015. Epub 2012 May 8.

PMID:
22489869
12.

The complex of immunoglobulin A and uromodulin as a diagnostic marker for immunoglobulin A nephropathy.

Obara T, Mizoguchi S, Shimozuru Y, Sato T, Hotta O.

Clin Exp Nephrol. 2012 Oct;16(5):713-21. doi: 10.1007/s10157-012-0617-3. Epub 2012 Mar 14.

13.

[Primary retroperitoneal carcinoid tumor associated with multiple endcrine neoplasia (men) type 1: a case report].

Chiba S, Numakura K, Satoyoshi K, Saito M, Horikawa Y, Takayama K, Nara T, Kanda S, Miura Y, Maita S, Tsuruta H, Obara T, Kumazawa T, Narita S, Tsuchiya N, Satoh S, Habuchi T.

Nihon Hinyokika Gakkai Zasshi. 2011 Nov;102(6):735-9. Japanese.

PMID:
22390089
14.

Short-term clinicopathological outcome of neoadjuvant chemohormonal therapy comprising complete androgen blockade, followed by treatment with docetaxel and estramustine phosphate before radical prostatectomy in Japanese patients with high-risk localized prostate cancer.

Narita S, Tsuchiya N, Kumazawa T, Maita S, Numakura K, Obara T, Tsuruta H, Saito M, Inoue T, Horikawa Y, Satoh S, Nanjyo H, Habuchi T.

World J Surg Oncol. 2012 Jan 4;10:1. doi: 10.1186/1477-7819-10-1.

15.

[Granulocyte colony stimulating factor-producing spindle cell renal cell carcinoma successfully treated by chemotherapy consisting of gemcitabine and doxorubicin].

Kanda S, Inoue T, Tsuruta H, Chiba S, Obara T, Saito M, Kumazawa T, Tsuchiya N, Satoh S, Habuchi T.

Hinyokika Kiyo. 2011 Jul;57(7):385-9. Japanese.

16.

Overexpression of Fn14 promotes androgen-independent prostate cancer progression through MMP-9 and correlates with poor treatment outcome.

Huang M, Narita S, Tsuchiya N, Ma Z, Numakura K, Obara T, Tsuruta H, Saito M, Inoue T, Horikawa Y, Satoh S, Habuchi T.

Carcinogenesis. 2011 Nov;32(11):1589-96. doi: 10.1093/carcin/bgr182. Epub 2011 Aug 8.

PMID:
21828059
17.

Outcome, clinical prognostic factors and genetic predictors of adverse reactions of intermittent combination chemotherapy with docetaxel, estramustine phosphate and carboplatin for castration-resistant prostate cancer.

Narita S, Tsuchiya N, Yuasa T, Maita S, Obara T, Numakura K, Tsuruta H, Saito M, Inoue T, Horikawa Y, Satoh S, Habuchi T.

Int J Clin Oncol. 2012 Jun;17(3):204-11. doi: 10.1007/s10147-011-0275-6. Epub 2011 Jun 25.

PMID:
21706123
18.

Correlations between pretransplant dialysis duration, bladder capacity, and prevalence of vesicoureteral reflux to the graft.

Inoue T, Satoh S, Saito M, Numakura K, Tsuruta H, Obara T, Narita S, Horikawa Y, Tsuchiya N, Habuchi T.

Transplantation. 2011 Aug 15;92(3):311-5. doi: 10.1097/TP.0b013e318223d7d6.

PMID:
21659949
19.

What is the most preferred wound site for laparoscopic donor nephrectomy?: a questionnaire assessment.

Saito M, Tsuchiya N, Maita S, Numakura K, Obara T, Tsuruta H, Kumazawa T, Inoue T, Narita S, Horikawa Y, Yuasa T, Satoh S, Habuchi T.

J Laparoendosc Adv Surg Tech A. 2011 Jul-Aug;21(6):511-5. doi: 10.1089/lap.2010.0457. Epub 2011 May 11.

PMID:
21561338
20.

A case of intratesticular endometrioid papillary cystadenocarcinoma.

Numakura K, Tsuchiya N, Tsuruta H, Obara T, Saito M, Inoue T, Narita S, Horikawa Y, Satoh S, Nanjyo H, Habuchi T.

Jpn J Clin Oncol. 2011 May;41(5):674-6. doi: 10.1093/jjco/hyr038. Epub 2011 Apr 7.

PMID:
21474549

Supplemental Content

Loading ...
Support Center